Title:
METHOD FOR SUPPRESSING RAS ACTIVATED IN CELL BY USING ANTIBODY HAVING CYTOPLASM PENETRATION CAPACITY AND COMPLETE IMMUNOGLOBULIN FORM, AND USE FOR SAME
Document Type and Number:
WIPO Patent Application WO/2016/013871
Kind Code:
A1
Abstract:
The present invention relates to a method for suppressing RAS activated in a cell by using an antibody having cytoplasm penetration capacity and complete immunoglobulin form. In addition, the present invention relates to a heavy chain variable region (VH) that induces bonding, with RAS activated in a cytoplasm, by means of the active penetration, by an antibody having complete immunoglobulin form, of the cytoplasm of a living cell by endocytosis and endosomal escape, and an antibody comprising same. Also, the present invention relates to a method for treating cancer or tumors or for inhibiting the growth of cancer or tumor cells by using the antibody. The present invention also relates to a method for screening a heavy chain variable region that specifically bonds to RAS in a cytoplasm. The present invention also relates to a bioactive molecule fused to the antibody. The present invention also relates to a composition for preventing, treating or diagnosing cancer, comprising the antibody or the bioactive molecule fused to same. The present invention also relates to a polynucleotide that codes a light chain variable region and the antibody.
Inventors:
KIM YONG SUNG (KR)
CHOI DONG KI (KR)
SHIN SEUNG MIN (KR)
KIM SUNG HOON (KR)
CHOI DONG KI (KR)
SHIN SEUNG MIN (KR)
KIM SUNG HOON (KR)
Application Number:
PCT/KR2015/007627
Publication Date:
January 28, 2016
Filing Date:
July 22, 2015
Export Citation:
Assignee:
AJOU UNIV IND ACAD COOP FOUND (KR)
MEDICINAL BIOCONVERGENCE RES CT (KR)
MEDICINAL BIOCONVERGENCE RES CT (KR)
International Classes:
A61K39/395; A61K47/48; A61P35/00; C07K16/32; C07K16/46; C12N15/13; G01N33/53
Domestic Patent References:
| WO2003077945A1 | 2003-09-25 |
Foreign References:
| US20050288492A1 | 2005-12-29 | |||
| US20140179543A1 | 2014-06-26 |
Other References:
TANAKA, T. ET AL.: "Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation", EMBO J., vol. 22, no. 5, 2003, pages 1025 - 1035, XP008028868
MARSCHALL, A. L. J. ET AL.: "Targeting antibodies to the cytoplasm", MABS, vol. 3, no. 1, February 2011 (2011-02-01), pages 3 - 16
See also references of EP 3173099A4
MARSCHALL, A. L. J. ET AL.: "Targeting antibodies to the cytoplasm", MABS, vol. 3, no. 1, February 2011 (2011-02-01), pages 3 - 16
See also references of EP 3173099A4
Attorney, Agent or Firm:
KIM, SOON WOONG (KR)
κΉμμ (KR)
κΉμμ (KR)
Download PDF: